Reframing the Conversation Around Idiopathic Intracranial Hypertension

This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...
The New England Journal of Medicine

Case 32-2025: A 79-Year-Old Man with Dyspnea, Edema, and Pacemaker-Lead Displacement

A 79-year-old man was admitted to a hospital in Guangzhou, China, with progressive dyspnea and edema. Echocardiography and ...
abc27

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...
MarketWatch

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE(R) VIABAHN(R) FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP ...

The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...
Endovascular Today

CREST-2 Shows Reduced Stroke Risk With Carotid Artery Stenting Plus Intensive Medical Management; No Added Benefit Seen With CEA

In a pair of randomized, observer-blinded clinical trials designed to evaluate optimal management of asymptomatic carotid ...
Yahoo Finance

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

Recana Thrombectomy Catheter System is designed to address the challenges of venous in-stent restenosis and residual thrombotic obstructions and occlusions. REDWOOD CITY, Calif., October 31, ...
Nature

Antenatal thrombosis of torcular herophili presenting with anemia, consumption coagulopathy and high-output cardiac failure in a preterm infant

Dural sinus malformation occasionally results in the development of giant venous lakes involving torcular herophili. Such dilatation can result in the formation of a ...
Medical Device Network on MSN

Gore’s venous stent study meets primary endpoint

The trial assessed the performance of the device over 12 months in individuals experiencing symptomatic deep venous disease.
Hosted on MSN

FDA clears InterVene’s in-stent restenosis catheter

InterVene’s Recana, a mechanical thrombectomy catheter designed to address venous in-stent restenosis (ISR) and clear vessel obstructions, has received 510(k) clearance from the US Food and Drug ...
Eagle-Tribune

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions

InterVene, Inc., a privately held medical device company pioneering interventional devices for venous occlusions, today announced it received 510(k) clearance from the U.S. Food and Drug ...
TCTMD

TCT 1925: Venous Angioplasty as an Emergency Intervention for Pacemaker Placement: Navigating Unforeseen Challenges

TCT 1366: Devil's Dager or Cupid's Arrow: Percutaneous Removal of Fractured IVC Filter Strut From Across the Septum Receive the the latest news, research, and presentations from major meetings right ...